|

OBX-115 Clinical Trials

1 actively recruiting trial across 1 location

Pipeline

Phase 1/2: 1

Top Sponsors

  • Obsidian Therapeutics, Inc.1

Indications

  • Tumor Skin1
  • Metastatic Non-Small Cell Lung Cancer1
  • Metastatic Lung Cancer1
  • Metastatic Melanoma1
  • Melanoma1

Los Angeles, California1 trial

Safety and Efficacy of OBX-115 in Advanced Solid Tumors

The Angeles Clinic and Research Institute (Melanoma)

Phase 1/2

Trial data from ClinicalTrials.gov. Trial status and eligibility can change — verify directly with the study contact or on ClinicalTrials.gov.

This site does not provide medical advice. Always consult your doctor before considering enrollment in a clinical trial. Learn more on our About page.